Aybala Temel profile image
Aybala Temel Asst. Prof. Dr. IZMIR KATIP CELEBI UNIVERSITY, FACULTY OF PHARMACY
Publication 1 Review 6 TR Dizin Cited 10
1 Publication
6 Review
10 TR Dizin Cited
0000-0003-1549-7219

Research Fields

Bacteriology Pharmacology and Pharmaceutical Sciences

Institution

IZMIR KATIP CELEBI UNIVERSITY, FACULTY OF PHARMACY

Popular Publications

EVALUATION OF AST FAST ES/NF AGAR MEDIUM FOR RAPID DETECTION OF IMIPENEM RESISTANCE IN CLINICAL KLEBSIELLA PNEUMONIAE AND ACINETOBACTER BAUMANNII ISOLATES
Authors: Aybala Temel , Yamaç Tekintaş , Mine Hoşgör Limoncu , Feriha Cilli
Published: 2023 , Journal of Faculty of Pharmacy of Ankara University
DOI: 10.33483/jfpau.1230197
CITED 0 FAVORITE 1 TOTAL DOWNLOAD COUNT 695

0

1

695

Publications

EVALUATION OF AST FAST ES/NF AGAR MEDIUM FOR RAPID DETECTION OF IMIPENEM RESISTANCE IN CLINICAL KLEBSIELLA PNEUMONIAE AND ACINETOBACTER BAUMANNII ISOLATES
Authors: Aybala Temel , Yamaç Tekintaş , Mine Hoşgör Limoncu , Feriha Cilli
Published: 2023 , Journal of Faculty of Pharmacy of Ankara University
DOI: 10.33483/jfpau.1230197
FAVORITE 1 TOTAL DOWNLOAD COUNT 695

1

695

Articles published in
Journal of Faculty of Pharmacy of Ankara University
Journal of Faculty of Pharmacy of Ankara University

Reviews

Health Sciences Journal of Adıyaman University
Health Sciences Journal of Adıyaman University
Journal of Faculty of Pharmacy of Ankara University
Journal of Faculty of Pharmacy of Ankara University
Van Health Sciences Journal
Van Health Sciences Journal
There are no Crossref cited.
Popular Publications: It is determined automatically by the researchers doing research in DergiPark according to the statistics of being added to the favorites. CrossRef Cited: The citations shown in DergiPark are drawn from CrossRef. For this, the cited and cited articles must be registered in CrossRef (DOI number). ^: Citation numbers are reflected in the system by DergiPark at certain periods.
Interactive Guide Tool
If you want to see the panel introduction, you can click Start Tour.